206 related articles for article (PubMed ID: 10696071)
21. Detection of anti-DNA topoisomerase I antibody by an enzyme-linked immunosorbent assay using overlapping recombinant polypeptides.
Kuwana M; Medsger TA; Wright TM
Clin Immunol Immunopathol; 1995 Sep; 76(3 Pt 1):266-78. PubMed ID: 7554448
[TBL] [Abstract][Full Text] [Related]
22. Different distribution of HLA class II alleles in anti-topoisomerase I autoantibody responders between silicosis and systemic sclerosis patients, with a common distinct amino acid sequence in the HLA-DQB1 domain.
Ueki A; Isozaki Y; Tomokuni A; Ueki H; Kusaka M; Tanaka S; Otsuki T; Sakaguchi H; Hyodoh F
Immunobiology; 2001 Dec; 204(4):458-65. PubMed ID: 11776400
[TBL] [Abstract][Full Text] [Related]
23. Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody.
Kuwana M; Kaburaki J; Arnett FC; Howard RF; Medsger TA; Wright TM
Arthritis Rheum; 1999 Mar; 42(3):465-74. PubMed ID: 10088769
[TBL] [Abstract][Full Text] [Related]
24. MHC class II associations with autoantibody and T cell immune responses to the scleroderma autoantigen topoisomerase I.
Rands AL; Whyte J; Cox B; Hall ND; McHugh NJ
J Autoimmun; 2000 Dec; 15(4):451-8. PubMed ID: 11090244
[TBL] [Abstract][Full Text] [Related]
25. Analysis of anti-topoisomerase I antibodies in patients with systemic sclerosis before and after autologous stem cell transplantation.
Henes J; Glaeser L; Kötter I; Vogel W; Kanz L; Klein R
Rheumatology (Oxford); 2017 Mar; 56(3):451-456. PubMed ID: 27940597
[TBL] [Abstract][Full Text] [Related]
26. Mapping of the immunodominant T cell epitopes of the protein topoisomerase I.
Veeraraghavan S; Renzoni EA; Jeal H; Jones M; Hammer J; Wells AU; Black CM; Welsh KI; du Bois RM
Ann Rheum Dis; 2004 Aug; 63(8):982-7. PubMed ID: 15249326
[TBL] [Abstract][Full Text] [Related]
27. Anti-DNA topoisomerase IIalpha autoantibodies in localized scleroderma.
Hayakawa I; Hasegawa M; Takehara K; Sato S
Arthritis Rheum; 2004 Jan; 50(1):227-32. PubMed ID: 14730620
[TBL] [Abstract][Full Text] [Related]
28. Autoantibodies against topoisomerase I detected with the natural enzyme and overlapping recombinant peptides.
Seelig HP; Schröter H; Ehrfeld H; Renz M
J Immunol Methods; 1993 Oct; 165(2):241-52. PubMed ID: 8228274
[TBL] [Abstract][Full Text] [Related]
29. Molecular recognition patterns of serum anti-DNA topoisomerase I antibody in systemic sclerosis.
Hu PQ; Fertig N; Medsger TA; Wright TM
J Immunol; 2004 Aug; 173(4):2834-41. PubMed ID: 15295002
[TBL] [Abstract][Full Text] [Related]
30. Analysis of an immunodominant epitope of topoisomerase I in patients with systemic sclerosis.
Meesters TM; Hoet M; van den Hoogen FH; Verheijen R; Habets WJ; van Venrooij WJ
Mol Biol Rep; 1992 May; 16(2):117-23. PubMed ID: 1318998
[TBL] [Abstract][Full Text] [Related]
31. Heparin inhibits the interaction of DNA topoisomerase I/anti-topoisomerase I immune complexes with heparan sulfate on dermal fibroblasts.
Arcand J; Robitaille G; Koenig M; Senécal JL; Raymond Y
Arthritis Rheum; 2012 May; 64(5):1632-41. PubMed ID: 22095242
[TBL] [Abstract][Full Text] [Related]
32. The level of anti-topoisomerase I antibodies highly correlates with metacarpophalangeal and proximal interphalangeal joints flexion contractures in patients with systemic sclerosis.
Radić M; Martinović Kaliterna D; Ljutić D
Clin Exp Rheumatol; 2006; 24(4):407-12. PubMed ID: 16956431
[TBL] [Abstract][Full Text] [Related]
33. IgG reactivity with a 100-kDa tissue and endothelial cell antigen identified as topoisomerase 1 distinguishes between limited and diffuse systemic sclerosis patients.
García de la Peña-Lefebvre P; Chanseaud Y; Tamby MC; Reinbolt J; Batteux F; Allanore Y; Kahan A; Meyer O; Benveniste O; Boyer O; Guillevin L; Boissier MC; Mouthon L
Clin Immunol; 2004 Jun; 111(3):241-51. PubMed ID: 15183145
[TBL] [Abstract][Full Text] [Related]
34. Epitope Specificity Determines Pathogenicity and Detectability of Anti-Platelet-Derived Growth Factor Receptor α Autoantibodies in Systemic Sclerosis.
Moroncini G; Grieco A; Nacci G; Paolini C; Tonnini C; Pozniak KN; Cuccioloni M; Mozzicafreddo M; Svegliati S; Angeletti M; Kazlauskas A; Avvedimento EV; Funaro A; Gabrielli A
Arthritis Rheumatol; 2015 Jul; 67(7):1891-903. PubMed ID: 25808833
[TBL] [Abstract][Full Text] [Related]
35. Elevation of IgG levels is a serological indicator for pulmonary fibrosis in systemic sclerosis with anti-topoisomerase I antibodies and those with anticentromere antibody.
Komura K; Yanaba K; Ogawa F; Shimizu K; Takehara K; Sato S
Clin Exp Dermatol; 2008 May; 33(3):329-32. PubMed ID: 18312458
[TBL] [Abstract][Full Text] [Related]
36. Computational analysis of high-density peptide microarray data with application from systemic sclerosis to multiple sclerosis.
Hecker M; Lorenz P; Steinbeck F; Hong L; Riemekasten G; Li Y; Zettl UK; Thiesen HJ
Autoimmun Rev; 2012 Jan; 11(3):180-90. PubMed ID: 21621003
[TBL] [Abstract][Full Text] [Related]
37. A recombinant topoisomerase I ELISA: screening for IgG, IgM and IgA anti-topo I autoantibodies in human sera.
Verheijen R; de Jong BA; van Venrooij WJ
Clin Exp Immunol; 1992 Sep; 89(3):456-60. PubMed ID: 1325307
[TBL] [Abstract][Full Text] [Related]
38. Diversity and plasticity of the anti-DNA topoisomerase I autoantibody response in scleroderma.
Henry PA; Atamas SP; Yurovsky VV; Luzina I; Wigley FM; White B
Arthritis Rheum; 2000 Dec; 43(12):2733-42. PubMed ID: 11145031
[TBL] [Abstract][Full Text] [Related]
39. Identification of an immunodominant epitope on RNA polymerase III recognized by systemic sclerosis sera: application to enzyme-linked immunosorbent assay.
Kuwana M; Kimura K; Kawakami Y
Arthritis Rheum; 2002 Oct; 46(10):2742-7. PubMed ID: 12384934
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of topoisomerase-1-specific CD8+ T-cell response in systemic sclerosis.
Boin F; Wigley FM; Schneck JP; Oelke M; Rosen A
Ann N Y Acad Sci; 2005 Dec; 1062():137-45. PubMed ID: 16461796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]